yripharm Enterprises Inc and ABB, Inc. collaborate on the design and development of Automation and Robotics to advance Testing Laboratory Platform for Public Health and Public Safety
HOUSTON--(BUSINESS WIRE)--Vyripharm Enterprises Inc. (VEI), a Texas biopharmaceutical/biotechnology company based in the Texas Medical Center (TMC) in Houston, and ABB Robotics, a leading global technology company headquartered in Zürich, Switzerland, have signed an agreement towards the development of an automated laboratory testing platform.
Vyripharm Enterprises Inc. held its 2022 Legislative Summit For Public Health and Public Safety with Keynote Speaker Congressman Dan Crenshaw
HOUSTON--(BUSINESS WIRE)--Vyripharm Enterprises Inc. and BIZPAC.US hosted the First Annual Vyripharm Public Health and Safety Legislative Reception on August 31, 2022 at the Texas Medical Center (TMC) Institute Innovation Factory, TMC's 1st phase biotech incubator and accelerator.
Vyripharm Enterprises, Inc. and Colorado State University Pueblo Announce Sponsored Research and Facilities Agreement
HOUSTON & PUEBLO, Colo., March 10, 2022--(BUSINESS WIRE)--Vyripharm Enterprises, Inc. and CSU Pueblo announced today a partnership to support the creation of a comprehensive testing and certification laboratory that will provide the first consistent scientific analysis within cannabinoid research.